Mechanism Capital’s Andrew Kang said DeSci protocols will likely change their existing models before evolving into more market-ready products.

DeSci, Healthcare, Andrew Kang, Mechanism Capital, BIO Protocol, Pump Science, GLP1, OriginTrailRead More

You might also be interested in reading Kucoin’s Legal Woes Spark Massive $1.7 Billion Withdrawal, Onchain Data Reveals.